Abstract
Factor XIa is a serine protease expressed as a zymogen that is converted to its active form, XIa, by factor XIIa and by thrombin, and plays a major role in amplification of thrombotic response to maintaining clot activity. The 3D-QSAR study of α-ketotiazole arginine analogue inhibitors of coagulation factor XIa were developed using CoMFA and CoMSIA models that showed excellent internal predictability and consistency, while validation using test-set compounds yielded a good predictive power for pIC50. The CoMFA model with steric and electrostatic fields provided satisfactory statistical data (q2 = 0.632 and q2cv = 0.957) and CoMSIA model with steric, electrostatic, hydrophobic, H-bond donor and acceptor exhibited q2 = 0.683 and q2cv = 0.853. Interaction between receptor and ligands most importantly are H-bond hydrogens, salt bridge. The information obtained from both CoMFA and CoMSIA 3D contour maps may be used in the design of new coagulation factor XIa inhibitors.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
